홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium Iodide → 6-Butyl-8-[(1-{4-[(1,1-di methylethyl)sulfonyl]butyl}-4-piperidinyl)oxy]quinoline, formate salt

HRID 1363023
인쇄

반응식

HRID 1363023 반응식
[CH2:1]([C:5]1[CH:6]=[C:7]2[C:12](=[C:13]([O:15][CH:16]3[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]3)[CH:14]=1)[N:11]=[CH:10][CH:9]=[CH:8]2)[CH2:2][CH2:3][CH3:4].[I-].[Na+].[C:24](=O)([OH:26])[O-:25].[Na+].[CH3:29][C:30]([S:33]([CH2:36][CH2:37][CH2:38][CH2:39]Br)(=[O:35])=[O:34])([CH3:32])[CH3:31]>CN(C=O)C.CO>[CH:24]([OH:26])=[O:25].[CH2:1]([C:5]1[CH:6]=[C:7]2[C:12](=[C:13]([O:15][CH:16]3[CH2:17][CH2:18][N:19]([CH2:39][CH2:38][CH2:37][CH2:36][S:33]([C:30]([CH3:29])([CH3:32])[CH3:31])(=[O:34])=[O:35])[CH2:20][CH2:21]3)[CH:14]=1)[N:11]=[CH:10][CH:9]=[CH:8]2)[CH2:2][CH2:3][CH3:4]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 5238Sodium IodideHCID 516892Sodium BicarbonateHCID 434445051-Bromo-4-(tert-butylsulfonyl)butane2회HCID 579260486-Butyl-8-(4-piperidinyloxy)quinoline2회

생성물 1

HCID 1317286546-Butyl-8-[(1-{4-[(1,1-di methylethyl)sulfonyl]butyl}-4-piperidinyl)oxy]quinoline, formate salt수율 49.8%

시약·촉매·용매

2
HCID 887Methanol용매HCID 6228Dimethylformamide용매

반응 조건

온도
150 °C

실험 절차

A mixture of 6-butyl-8-(4-piperidinyloxy)quinoline (for example, as prepared for Intermediate 4) (65 mg, 0.23 mmol), sodium iodide (47 mg, 0.3 mmol), sodium bicarbonate (190 mg, 2.2 mmol) and 4-bromobutyl 1,1-dimethylethyl sulfone (for example, as prepared for Intermediate 22) (94 mg) in DMF (2 ml) was heated in a Smith Creator™ microwave oven at 150° C. for 20 min. The reaction mixture was applied to an SCX-2 cartridge (10 g), preconditioned with methanol, and eluted with methanol, followed by 10% aqueous 0.88 s.g. ammonia in methanol. The ammoniacal fractions were combined and concentrated in vacuo and the residue (100 mg) was purified by MDAP to give the title compound (58 mg, 46%): LCMS RT=2.65 min, ES+ve m/z 461 (M+H)+.

후처리

  1. washeluted with methanol
  2. customfollowed by 10% aqueous 0.88 s
  3. concentrationconcentrated in vacuo
  4. customthe residue (100 mg) was purified by MDAP

출처 및 근거

ORD 기록
ord-9154c77da73e436da2b2b34738348fc5
출처 데이터셋
uspto-grants-2011_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07884114B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트